Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced Nov. 17 a long-term commercial manufacturing partnership with Orca Bio, a commercial-stage biotechnology company developing high-precision cell therapies for blood cancers and autoimmune diseases.
Under the partnership, Made Scientific will provide manufacturing capacity in Princeton for TREGZI, Orca Bio’s FDA-approved, precision-engineered cell therapy for allogeneic transplant in adults with hematological malignancies.